Shandong Xinhua Pharmaceutical (00719) said its net profit attributable to the shareholders for the first quarter of 2016 rose 42.34% year-on-year to Rmb20.297 million.
Basic and diluted earnings per share were Rmb4 cents.
Operating income was Rmb1,005 million, an increase of 0.53% from a year earlier.